OSE Immunotherapeutics SA

OSE Immunotherapeutics SAverified

OSE.PA

Price:

$7.5

Market Cap:

$163.15M

OSE Immunotherapeutics SA focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. Its products include Tedopi that is in Phase III clinical stage for the treatment of non-small cell lung cancer, as well as in Phase II clinical trial to pancreatic and ovarian cancer; CoVepiT, a prophylactic vaccine against the SARS-CoV-2 virus; BI 765063, which is in Phase I clinical trial to treat solid tumors; and BiCKI, a novel bispecific checkpoint inhibitor platform, targeting PD-1 and innovative targets to fight primary and secondary resistance mechanisms developed by cancers. The company's products also comprise OSE-12...[Read more]

Industry

Biotechnology

IPO Date

2015-03-30

Stock Exchange

EURONEXT

Ticker

OSE.PA

The Enterprise Value as of September 2024 (TTM) for OSE Immunotherapeutics SA (OSE.PA) is 190.28M

According to OSE Immunotherapeutics SA’s latest financial reports and current stock price. The company's current Enterprise Value is 190.28M. This represents a change of 63.21% compared to the average of 116.58M of the last 4 quarters.

OSE Immunotherapeutics SA (OSE.PA) Historical Enterprise Value (quarterly & annually)

How has OSE.PA Enterprise Value performed in the past?

The mean historical Enterprise Value of OSE Immunotherapeutics SA over the last ten years is 92.33M. The current 190.28M Enterprise Value has changed 20.51% with respect to the historical average. Over the past ten years (40 quarters), OSE.PA's Enterprise Value was at its highest in in the June 2021 quarter at 206.62M. The Enterprise Value was at its lowest in in the June 2013 quarter at 0.

Quarterly (TTM)
Annual

Average

92.33M

Median

82.39M

Minimum

40.74M

Maximum

190.19M

OSE Immunotherapeutics SA (OSE.PA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of OSE Immunotherapeutics SA Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 150.73%

Maximum Annual Enterprise Value = 190.19M

Minimum Annual Increase = -36.60%

Minimum Annual Enterprise Value = 40.74M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023110.85M-22.14%
2022142.38M-25.14%
2021190.19M86.19%
2020102.15M150.73%
201940.74M-14.49%
201847.65M-9.56%
201752.68M-36.60%
201683.10M15.56%
201571.91M-11.96%
201481.68M1.30%

OSE Immunotherapeutics SA (OSE.PA) Average Enterprise Value

How has OSE.PA Enterprise Value performed in the past?

The current Enterprise Value of OSE Immunotherapeutics SA (OSE.PA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

147.81M

5-year avg

117.26M

10-year avg

92.33M

OSE Immunotherapeutics SA (OSE.PA) Enterprise Value vs. Peers

How is OSE.PA’s Enterprise Value compared to its peers?

OSE Immunotherapeutics SA’s Enterprise Value is greater than Innate Pharma S.A. (135.23M), greater than Quantum Genomics Société Anonyme (148.95K), less than Valneva SE (451.99M), greater than Poxel S.A. (25.71M), greater than Nanobiotix S.A. (185.12M),

CompanyEnterprise ValueMarket cap
135.23M$165.95M
148.95K$979.50K
451.99M$373.76M
25.71M$28.05M
185.12M$209.83M

Build a custom stock screener for OSE Immunotherapeutics SA (OSE.PA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OSE Immunotherapeutics SA using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

OSE Immunotherapeutics SA (OSE.PA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like OSE Immunotherapeutics SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is OSE Immunotherapeutics SA's Enterprise Value?

What is the highest Enterprise Value for OSE Immunotherapeutics SA (OSE.PA)?

What is the 3-year average Enterprise Value for OSE Immunotherapeutics SA (OSE.PA)?

What is the 5-year average Enterprise Value for OSE Immunotherapeutics SA (OSE.PA)?

How does the current Enterprise Value for OSE Immunotherapeutics SA (OSE.PA) compare to its historical average?